Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Hajar Rajayi, Parsova Tavasolian, Alaleh Rezalotfi & Marzieh Ebrahimi. (2019) Cancer Stem Cells Targeting; the Lessons from the Interaction of the Immune System, the Cancer Stem Cells and the Tumor Niche. International Reviews of Immunology 38:6, pages 267-283.
Read now
Read now
Elena Lo Presti, Anna Maria Corsale, Francesco Dieli & Serena Meraviglia. (2019) γδ cell-based immunotherapy for cancer. Expert Opinion on Biological Therapy 19:9, pages 887-895.
Read now
Read now
Teruki Shimizu, Mako Tomogane, Masatsugu Miyashita, Osamu Ukimura & Eishi Ashihara. (2018) Low dose gemcitabine increases the cytotoxicity of human Vγ9Vδ2 T cells in bladder cancer cells in vitro and in an orthotopic xenograft model. OncoImmunology 7:5.
Read now
Read now
S. Meraviglia, E. Lo Presti, M. Tosolini, C. La Mendola, V. Orlando, M. Todaro, V. Catalano, G. Stassi, G. Cicero, S. Vieni, J. J. Fourniè & F. Dieli. (2017) Distinctive features of tumor-infiltrating γδ T lymphocytes in human colorectal cancer. OncoImmunology 6:10.
Read now
Read now
Jaydeep Bhat & Dieter Kabelitz. (2015) γδ T cells and epigenetic drugs: A useful merger in cancer immunotherapy?. OncoImmunology 4:6.
Read now
Read now
Articles from other publishers (26)
Yi Hu, Qinglin Hu, Yongsheng Li, Ligong Lu, Zheng Xiang, Zhinan Yin, Dieter Kabelitz & Yangzhe Wu. (2023) γδ T cells: origin and fate, subsets, diseases and immunotherapy. Signal Transduction and Targeted Therapy 8:1.
Crossref
Crossref
Piotr J. Wysocki, Maciej T. Lubas & Malgorzata L. Wysocka. (2022) Metronomic Chemotherapy in Prostate Cancer. Journal of Clinical Medicine 11:10, pages 2853.
Crossref
Crossref
Xiangjin Zhang, Yi Xu, Hui Chen, Jianmin Zhang & Wei He. (2022) γδT cells: alternative treasure in antitumor immunity. Exploration of Immunology, pages 32-47.
Crossref
Crossref
Chenxiao Liu, Karolina Skorupinska-Tudek, Sven-Göran Eriksson & Ingela Parmryd. (2022) Potentiating Vγ9Vδ2 T cell proliferation and assessing their cytotoxicity towards adherent cancer cells at the single cell level. Biology Open 11:1.
Crossref
Crossref
Lawrence S. Lamb, Larisa Pereboeva, Samantha Youngblood, G. Yancey Gillespie, L. Burton Nabors, James M. Markert, Anindya Dasgupta, Catherine Langford & H. Trent Spencer. (2021) A combined treatment regimen of MGMT-modified γδ T cells and temozolomide chemotherapy is effective against primary high grade gliomas. Scientific Reports 11:1.
Crossref
Crossref
Ahmed Al Otaibi, Subuhi Sherwani, Salma Ahmed Al-Zahrani, Eida Mohammed Alshammari, Wahid Ali Khan, Abdulmohsen Khalaf D. Alsukaibi, Shahper Nazeer Khan & Mohd Wajid Ali Khan. (2021) Biologically Active α-Amino Amide Analogs and γδ T Cells—A Unique Anticancer Approach for Leukemia. Frontiers in Oncology 11.
Crossref
Crossref
Mei Guo, Chengzhong You, Wenqi Dong, Biao Luo, Yuheng Wu, Yanuo Chen, Jianping Li, Meng Pan, Miao Li, Fengshu Zhao & Jun Dou. (2020) The surface dominant antigen MUC1 is required for colorectal cancer stem cell vaccine to exert anti-tumor efficacy. Biomedicine & Pharmacotherapy 132, pages 110804.
Crossref
Crossref
Michele Dal Bo, Elena De Mattia, Lorena Baboci, Silvia Mezzalira, Erika Cecchin, Yehuda G. Assaraf & Giuseppe Toffoli. (2020) New insights into the pharmacological, immunological, and CAR-T-cell approaches in the treatment of hepatocellular carcinoma. Drug Resistance Updates 51, pages 100702.
Crossref
Crossref
Karin Schilbach, Christian Welker, Naomi Krickeberg, Carlotta Kaißer, Sabine Schleicher & Hisayoshi Hashimoto. (2020) In the Absence of a TCR Signal IL-2/IL-12/18-Stimulated γδ T Cells Demonstrate Potent Anti-Tumoral Function Through Direct Killing and Senescence Induction in Cancer Cells. Cancers 12:1, pages 130.
Crossref
Crossref
Bruno Silva-Santos, Sofia Mensurado & Seth B. Coffelt. (2019) γδ T cells: pleiotropic immune effectors with therapeutic potential in cancer. Nature Reviews Cancer 19:7, pages 392-404.
Crossref
Crossref
Ehsan Ghaedi, Nima Rezaei & Maryam Mahmoudi. 2019. Nutrition and Immunity. Nutrition and Immunity
209
281
.
Elena Lo Presti, Gabriele Pizzolato, Anna Maria Corsale, Nadia Caccamo, Guido Sireci, Francesco Dieli & Serena Meraviglia. (2018) γδ T Cells and Tumor Microenvironment: From Immunosurveillance to Tumor Evasion. Frontiers in Immunology 9.
Crossref
Crossref
Heleen H. Van Acker, Diana Campillo-Davo, Gils Roex, Maarten Versteven, Evelien L. Smits & Viggo F. Van Tendeloo. (2018) The role of the common gamma-chain family cytokines in γδ T cell-based anti-cancer immunotherapy. Cytokine & Growth Factor Reviews 41, pages 54-64.
Crossref
Crossref
Elena Lo Presti, Roberto Di Mitri, Gabriele Pizzolato, Filippo Mocciaro, Francesco Dieli & Serena Meraviglia. (2018) γδ cells and tumor microenvironment: A helpful or a dangerous liason?. Journal of Leukocyte Biology 103:3, pages 485-492.
Crossref
Crossref
Elena Lo Presti, Gabriele Pizzolato, Eliana Gulotta, Gianfranco Cocorullo, Gaspare Gulotta, Francesco Dieli & Serena Meraviglia. (2017) Current Advances in γδ T Cell-Based Tumor Immunotherapy. Frontiers in Immunology 8.
Crossref
Crossref
Loretta Gammaitoni, Lidia Giraudo, Marco Macagno, Valeria Leuci, Giulia Mesiano, Ramona Rotolo, Francesco Sassi, Martina Sanlorenzo, Alessandro Zaccagna, Alberto Pisacane, Rebecca Senetta, Michela Cangemi, Giulia Cattaneo, Valentina Martin, Valentina Coha, Susanna Gallo, Ymera Pignochino, Anna Sapino, Giovanni Grignani, Fabrizio Carnevale-Schianca, Massimo Aglietta & Dario Sangiolo. (2017) Cytokine-Induced Killer Cells Kill Chemo-surviving Melanoma Cancer Stem Cells. Clinical Cancer Research 23:9, pages 2277-2288.
Crossref
Crossref
B. Calì, B. Molon & A. Viola. (2017) Tuning cancer fate: the unremitting role of host immunity. Open Biology 7:4, pages 170006.
Crossref
Crossref
Tomoharu Miyashita, Kenji Miki, Takashi Kamigaki, Isamu Makino, Hisatoshi Nakagawara, Hidehiro Tajima, Hiroyuki Takamura, Hirohisa Kitagawa, Sachio Fushida, Ali K. Ahmed, Mark D. Duncan, John W. Harmon & Tetsuo Ohta. (2015) Low-dose gemcitabine induces major histocompatibility complex class I-related chain A/B expression and enhances an antitumor innate immune response in pancreatic cancer. Clinical and Experimental Medicine 17:1, pages 19-31.
Crossref
Crossref
Chang Zou, Pan Zhao, Zhangang Xiao, Xianghua Han, Fan Fu & Li Fu. (2016) γδ T cells in cancer immunotherapy. Oncotarget 8:5, pages 8900-8909.
Crossref
Crossref
Chloé Rancoule, Alexis Vallard, Sophie Espenel, Jean-Baptiste Guy, Yaoxiong Xia, Anis El Meddeb Hamrouni, Claire Rodriguez-Lafrasse, Cyrus Chargari, Eric Deutsch & Nicolas Magné. (2016) Immunotherapy in head and neck cancer: Harnessing profit on a system disruption. Oral Oncology 62, pages 153-162.
Crossref
Crossref
Nicolas André, Joseph Ciccolini, Marie Amélie Heng & Eddy Pasquier. 2016. Pharmacokinetics in Drug Development. Pharmacokinetics in Drug Development
189
207
.
Zhigang Zhang, Xiuyan Yu, Zhen Wang, Pin Wu & Jian Huang. (2015) Anthracyclines potentiate anti-tumor immunity: A new opportunity for chemoimmunotherapy. Cancer Letters 369:2, pages 331-335.
Crossref
Crossref
Muzammal Hussain, Fei Tang, Jinsong Liu, Jiancun Zhang & Aqeel Javeed. (2015) Dichotomous role of protein kinase A type I (PKAI) in the tumor microenvironment: A potential target for ‘two-in-one’ cancer chemoimmunotherapeutics. Cancer Letters 369:1, pages 9-19.
Crossref
Crossref
Elisabetta Munzone & Marco Colleoni. (2015) Clinical overview of metronomic chemotherapy in breast cancer. Nature Reviews Clinical Oncology 12:11, pages 631-644.
Crossref
Crossref
Qiao Li, Mark E.P. Prince & Jeffrey S. Moyer. (2015) Immunotherapy for head and neck squamous cell carcinoma. Oral Oncology 51:4, pages 299-304.
Crossref
Crossref
Nicolas André, Manon Carré & Eddy Pasquier. (2014) Metronomics: towards personalized chemotherapy?. Nature Reviews Clinical Oncology 11:7, pages 413-431.
Crossref
Crossref